Cerebral Palsy
Gene: MCCC2
1 individual reported with homozygous likely pathogenic missense variant in large-scale exome sequencing study (PMID: 38693247). Detailed clinical information not supplied. MCC2D is an autosomal recessive disorder of leucine catabolism. Highly variable clinical phenotype ranging from neonatal onset with severe neurologic involvement to asymptomatic adults. Additional individuals with a clinical diagnosis of CP or overlapping clinical presentation can be found in the literature (e.g. PMID: 9187484, PMID: 10485305)
Sources: LiteratureCreated: 19 Jun 2024, 3:10 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
3-Methylcrotonyl-CoA carboxylase 2 deficiency, MIM#210210
Publications
Gene: mccc2 has been classified as Amber List (Moderate Evidence).
Gene: mccc2 has been classified as Amber List (Moderate Evidence).
gene: MCCC2 was added gene: MCCC2 was added to Cerebral Palsy. Sources: Literature Mode of inheritance for gene: MCCC2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: MCCC2 were set to PMID: 38693247 Phenotypes for gene: MCCC2 were set to 3-Methylcrotonyl-CoA carboxylase 2 deficiency, MIM#210210 Review for gene: MCCC2 was set to AMBER